[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
July 1981

High-Density Lipoprotein Cholesterol in Cerebrovascular Disease

Author Affiliations

From the Department of Internal Medicine and the Laboratory of Biochemistry, Ciudad Sanitaria Seguridad Social, Universidad Autónoma, Barcelona, Spain.

Arch Neurol. 1981;38(7):468. doi:10.1001/archneur.1981.00510070102026

In recent years low levels of highdensity lipoproteins (HDLs) have been related to an increased risk of coronary heart disease (CHD). However, reports on HDL cholesterol (HDLC) in patients with cerebrovascular disease (CVD) are few and controversial. Rossner et al1 reported a decreased HDLC level in patients with CVD under the age of 55 years. Sirtori et al,2 in a similar age group, found decreased HDLC levels in men but not in women with CVD. Noma and co-workers3 showed a slight decrease, not statistically significant, in HDLC levels in 15 women with CVD over the age of 50 years, whereas no differences could be found in 13 men of similar age. Finally, Taggart and Stout,4 in aged subjects with CVD, observed a significant decrease of HDLC levels both in men and women.

The purpose of our study was to investigate serum HDLC levels in survivors